307 related articles for article (PubMed ID: 22260022)
1. [Lidamycin inhibits the proliferation of HERG K+ channel highly expressing cancer cells and shows synergy with anticancer drugs].
Shang BY; Shang Y; Zhen YS; Chen SZ
Yao Xue Xue Bao; 2011 Nov; 46(11):1321-5. PubMed ID: 22260022
[TBL] [Abstract][Full Text] [Related]
2. [Erythromycin inhibits the proliferation of HERG K+ channel highly expressing cancer cells and shows synergy with anticancer drugs].
Chen SZ; Zhang SH; Gong JH; Zhen YS
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(47):3353-7. PubMed ID: 17313833
[TBL] [Abstract][Full Text] [Related]
3. [Correlation of HERG K+ channel protein expression to chemosensitivity of tumor cells to doxorubicin and its modulation by erythromycin].
Chen SZ; Jiang M; Zhen YS
Ai Zheng; 2005 Aug; 24(8):924-9. PubMed ID: 16086867
[TBL] [Abstract][Full Text] [Related]
4. HERG K+ channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin.
Chen SZ; Jiang M; Zhen YS
Cancer Chemother Pharmacol; 2005 Aug; 56(2):212-20. PubMed ID: 15812674
[TBL] [Abstract][Full Text] [Related]
5. Lidamycin up-regulates the expression of thymidine phosphorylase and enhances the effects of capecitabine on the growth and pulmonary metastases of murine breast carcinoma.
Zhang SH; Zhang H; He HW; Li L; Li XQ; Zhang YP; Shao RG
Cancer Chemother Pharmacol; 2013 Oct; 72(4):777-88. PubMed ID: 23975242
[TBL] [Abstract][Full Text] [Related]
6. Chloroquine potentiates the anti-cancer effect of lidamycin on non-small cell lung cancer cells in vitro.
Liu F; Shang Y; Chen SZ
Acta Pharmacol Sin; 2014 May; 35(5):645-52. PubMed ID: 24727941
[TBL] [Abstract][Full Text] [Related]
7. [Bioluminescence imaging evaluation of the inhibitory effect of lidamycin on lung metastasis of human fibrosarcoma in athymic mice].
Zhang SH; Zhong GS; He HW; Cheng X; Zhen YS
Yao Xue Xue Bao; 2011 Jan; 46(1):45-9. PubMed ID: 21465808
[TBL] [Abstract][Full Text] [Related]
8. Lidamycin inhibits the cancer cell PKC activity induced by basic fibroblast growth factor.
Zhen HY; Huang YH; Zhen YS
Yao Xue Xue Bao; 2005 Dec; 40(12):1110-5. PubMed ID: 16496675
[TBL] [Abstract][Full Text] [Related]
9. [Synergistic effect and its possible mechanisms of lidamycin in combination with TRAIL in NSCLC].
Yang J; Chen SZ
Yao Xue Xue Bao; 2010 Oct; 45(10):1247-53. PubMed ID: 21348302
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
Chen J; Ouyang ZG; Zhang SH; Zhen YS
Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
[TBL] [Abstract][Full Text] [Related]
11. [Lidamycin induces apoptosis of human gastric carcinoma BGC823 cells and inhibits xenograft growth in nude mice].
Zhang SH; Chen J; Jiang M; Zhen YS
Yao Xue Xue Bao; 2008 Jun; 43(6):601-4. PubMed ID: 18822962
[TBL] [Abstract][Full Text] [Related]
12. HERG K+ channel related chemosensitivity to sparfloxacin in colon cancer cells.
Gong JH; Liu XJ; Shang BY; Chen SZ; Zhen YS
Oncol Rep; 2010 Jun; 23(6):1747-56. PubMed ID: 20428834
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of the antitumor activities of immunoconjugates composed of lidamycin and monoclonal antibody fab' fragment with different linkers].
Feng Y; Shao RG; Dai Y; Li BW; He HW; Ren KH
Yao Xue Xue Bao; 2010 May; 45(5):571-5. PubMed ID: 20931757
[TBL] [Abstract][Full Text] [Related]
14. Enediyne lidamycin enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib, in epidermoid carcinoma A431 cells and lung carcinoma H460 cells.
Liu H; Li L; Li XQ; Liu XJ; Zhen YS
Anticancer Drugs; 2009 Jan; 20(1):41-9. PubMed ID: 19342999
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of mouse embryonic carcinoma cell growth by lidamycin through down-regulation of embryonic stem cell-like genes Oct4, Sox2 and Myc.
Zhen HY; He QH; Zhen YZ; Wang SL; Liu YN; Wu WH; Zhang XY; Lu AL; Shen L
Invest New Drugs; 2011 Dec; 29(6):1188-97. PubMed ID: 20596749
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of anti-type IV collagenase monoclonal antibody and its lidamycin conjugate against colon carcinoma.
Li L; Huang YH; Li Y; Wang FQ; Shang BY; Zhen YS
World J Gastroenterol; 2005 Aug; 11(29):4478-83. PubMed ID: 16052675
[TBL] [Abstract][Full Text] [Related]
17. [The synergistic effect of lidamycin and rituximab on human B cell lymphoma].
Sun YR; Zhang SH; Shao RG; He HW
Yao Xue Xue Bao; 2014 Feb; 49(2):198-203. PubMed ID: 24761609
[TBL] [Abstract][Full Text] [Related]
18. [Antitumor activities of various immunoconjugates composed of lidamycin and anti-type IV collagenase monoclonal antibody].
Feng Y; Zhen YS; Dai Y; Shang BY; Zhang M; He HW; Li BW; Shao RG
Yao Xue Xue Bao; 2007 Jul; 42(7):704-9. PubMed ID: 17882952
[TBL] [Abstract][Full Text] [Related]
19. Antitumor efficacy of lidamycin against human multiple myeloma RPMI 8226 cells and the xenograft in nonobese diabetic/severe combined immunodeficiency mice.
Zhen Y; Shang B; Liu X; Lin Y; Zhen Y
J Cancer Res Ther; 2016; 12(1):182-7. PubMed ID: 27072234
[TBL] [Abstract][Full Text] [Related]
20. Synergy of enediyne antibiotic lidamycin and temozolomide in suppressing glioma growth with potentiated apoptosis induction.
Li XQ; Ouyang ZG; Zhang SH; Liu H; Shang Y; Li Y; Zhen YS
J Neurooncol; 2014 Aug; 119(1):91-100. PubMed ID: 24842385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
